investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Extraordinary responder cell lines reveal unique targetable genetic dependencies
Hugh S. Gannon
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Hugh S. Gannon
Dana-Farber Cancer Institute
Boston, United States
Related projects
Heide L Ford
Role of Six1 and the miR106b 25 Cluster in EMT and Tumor Progression
Breast
Larry Norton
Program Project in Models of Breast Cancer
Breast
Pathology
Marie C. Lee
Development of the Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk
Breast
Stuart Keith Calderwood
Extracellular Hsp70 and hyperthermia in tumor therapy
Breast
Mien-Chie Hung
Nuclear EGFR in Cancer Cell Signaling and Radioresistance
Breast
Radiation Oncology
Richard M Weinshilboum
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
Breast
Mara A Schonberg
Breast Cancer Risk Factors Among Women Aged 75 and Older
Breast
Scott I Abrams
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
Breast
Dana Pe'Er
Integrative Cancer Genomics: Drivers, Pathways and Drugs
Breast